Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

Advertisement
Advertisement
StocksAMGN

ETFs with exposure to Amgen, Inc. (AMGN)

1,388 ETFs hold Amgen, Inc. (AMGN)
Holdings data as of May 31, 2026
VanEck Biotech ETF - USD
This ETF provides exposure to US Biotechnology Equities
13.90%
+9.81%
+8.03%
-€55K
-€6.3M
€350M
0.35%
iShares Biotechnology ETF - USD
This ETF provides exposure to US Biotechnology Equities
7.13%
+12.17%
+12.60%
+€348M
-€146M
€8.06B
0.44%
Invesco Nasdaq Biotechnology ETF - USD
This ETF provides exposure to US Equities
7.10%
+11.62%
+15.23%
-€814K
-€559K
€64M
0.19%
Not rated
iShares Nasdaq US Biotechnology UCITS ETF (D) - USD
This ETF provides exposure to US Equities
Share class
Dist
USD
7.09%
+11.61%
+15.09%
+€269K
+€719K
€53M
0.35%
iShares Nasdaq US Biotechnology UCITS ETF - USD
This ETF provides exposure to US Equities
Share class
Acc
USD
7.09%
+11.61%
+15.09%
+€69M
+€32M
€884M
0.35%
Mirae Asset TIGER NASDAQ BIO ETF - KRW
This ETF provides exposure to US Equities
7.09%
+13.15%
+22.05%
-€2M
-€14M
€56M
0.3%
Not rated
CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF - TWD
This ETF provides exposure to US Equities
7.09%
+13.27%
+15.92%
€0
-€16K
€8.8M
1.01%
Not rated
Invesco NASDAQ Biotech UCITS ETF Acc - USD
This ETF provides exposure to US Equities
7.09%
+11.64%
+15.11%
+€14M
-€17M
€410M
0.4%
Amplify Weight Loss Drug & Treatment ETF - USD
This ETF provides exposure to Equities
6.02%
+5.42%
+1.56%
€0
+€1.3M
€3.8M
0.59%
Not rated
BMO Covered Call Health Care ETF - CAD
This ETF provides exposure to Health Care Equities
4.90%
+7.79%
-0.69%
+€2.4M
+€7.4M
€24M
0.73%
Not rated
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight